Study identification

EU PAS number

EUPAS1000000311

Study ID

1000000311

Official title and acronym

Investigating risk of cancer with Sodium-glucose cotransporter 2 inhibitors: a Case/Non-Case Study in the WHO Global Pharmacovigilance Database Vigibase

DARWIN EU® study

No

Study countries

France

Study description

Disproportionnality analysis using the WHO global database Vigibase.

Study status

Finalised
Research institutions and networks

Institutions

Contact details

Paul Gautier 0009-0008-9934-8432

Primary lead investigator
ORCID number:
0009-0008-9934-8432

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable